Publishing a medical imaging AI study in a Q1 journal takes clinical novelty, external validation, and transparent reporting, not a high accuracy score.
Publishing a medical imaging AI study in a Q1 journal takes clinical novelty, external validation, and transparent reporting, not a high accuracy score. For Vietnamese researchers entering fields like radiology, pathology, or neonatal imaging, a top-quartile journal such as IEEE Transactions on Medical Imaging judges a paper less on the headline metric and more on whether the method is rigorous, reproducible, and genuinely useful in the clinic.
This guide answers the seven questions Vietnamese researchers ask MAAS publishing mentors most often before submitting a medical-AI manuscript to a Q1 journal.
Author: MAAS AI & Health Sciences Publishing Desk · Reviewed by a Principal Publishing Advisor (PhD, Scopus Q1 author and reviewer in medical AI)
Last updated: 2026-06-04
Category: research-methods
What makes a medical imaging AI study publishable in a Q1 journal?
Direct answer: A Q1-publishable medical-AI study combines a clinically meaningful problem, a methodological contribution that advances on recent baselines, validation that holds up on data the model never saw, and reporting transparent enough for others to reproduce. A strong accuracy number on a single private dataset is not enough.
Evidence: Top imaging journals expect rigorous comparison to recent baselines on established benchmarks rather than results on a bespoke dataset alone, and increasingly expect a code-availability commitment (IEEE Transactions on Medical Imaging author guidance, 2024). A 2025 analysis of 347 medical imaging AI papers found that over 80% claimed their method was superior without statistical significance testing — exactly the weakness Q1 reviewers screen for (PMC meta-research, 2025).
Example: A Vietnamese researcher MAAS coached had a neonatal imaging model with high reported accuracy but only one institution's data and no significance testing. The mentor reframed the work around a clear clinical gap, added external validation and statistical comparison to two recent baselines, and the manuscript moved from a likely desk rejection to a competitive Q1 submission.
Which reporting guidelines must you follow for a medical-AI paper?
Direct answer: Use the reporting checklist that matches your study type and submit it with your manuscript. For an imaging AI model, CLAIM is the core checklist; for a clinical prediction model, use TRIPOD+AI; and align the overall design with the FUTURE-AI trustworthiness principles. Many Q1 journals now request one of these at submission.
Evidence: The Checklist for Artificial Intelligence in Medical Imaging (CLAIM) 2024 Update was published in Radiology: Artificial Intelligence on 29 May 2024 by a 72-member panel and is hosted on the EQUATOR Network. TRIPOD+AI, a 27-item checklist published in The BMJ in 2024, supersedes the 2015 TRIPOD statement for prediction-model reporting. FUTURE-AI (2024), built by a consortium of 118 experts from 51 countries, defines six guiding principles for trustworthy healthcare AI.
| Guideline | Year | Use it when | Focus |
|---|---|---|---|
| CLAIM (2024 update) | 2024 | Your study develops or evaluates an imaging AI model | Transparent, reproducible imaging-AI reporting |
| TRIPOD+AI | 2024 | You build or validate a clinical prediction model | Standardised prediction-model reporting (regression or ML) |
| FUTURE-AI | 2024 | Designing for clinical trustworthiness/deployment | Fairness, robustness, traceability, usability, explainability |
Example: A MAAS-coached pathology AI author filled in CLAIM line by line during the Draft stage. Three items she could not answer — data provenance, external test set, and failure-case analysis — became her revision checklist, and addressing them strengthened the paper before reviewers ever saw it.
How do you choose the right Q1 journal for a medical-AI study?
Direct answer: Match your contribution to the journal's scope before you write the cover letter. A methods-heavy model fits a technical venue like IEEE Transactions on Medical Imaging or Medical Image Analysis; a clinically framed study fits Radiology: Artificial Intelligence. Read recent issues, confirm the journal expects your benchmark, and verify it is indexed in Scopus or Web of Science.
Evidence: IEEE TMI expects rigorous comparison on established benchmarks such as fastMRI for reconstruction or AAPM challenge data for CT, and applies a roughly 10-page limit with the methodological contribution visible in the introduction (IEEE TMI author guidance, 2024). Scope mismatch remains the most common reason manuscripts are rejected at editorial triage before peer review, so journal fit is a decisive early choice.
Example: A Vietnamese doctoral candidate wanted to send a clinically oriented diagnostic study to a hard technical-methods journal. Her MAAS mentor flagged the mismatch, compared two better-fit Q1 imaging journals against her contribution, and the resubmission read as a natural fit rather than a stretch.
What dataset and validation standards do Q1 reviewers expect?
Direct answer: Q1 reviewers expect validation on data the model never saw during training — ideally an external dataset from a different institution or scanner — plus a clean train/validation/test split with no patient overlap. External validation and leakage control are now baseline expectations, not bonus features.
Evidence: A frequent and serious source of bias is data leakage, such as including different scans from the same patient in both training and validation sets, which inflates apparent performance (PMC review of bias in medical imaging AI, 2025). Nearly half of deep-learning models that undergo external testing show at least a modest performance drop, and shortcut learning of hidden acquisition biases can overestimate performance by up to 20% — which is why reviewers probe generalisation hard.
Example: A MAAS Publishing Advisory client had trained and tested on images from one hospital. Her mentor helped her source a small public external dataset for an independent test, document the train/test separation explicitly, and report the honest performance drop — a transparency move reviewers rewarded rather than penalised.
Why do strong models still get rejected from Q1 journals?
Direct answer: Even an accurate model is rejected when the paper overclaims, skips statistical testing, lacks external validation, or hides failure cases. Reviewers read these as signs the result may not hold up, and at Q1 level the burden of proof sits with the author.
Evidence: The 2025 analysis of 347 medical imaging AI publications found 86% showed a high probability of false outperformance claims, largely because superiority was asserted without significance testing (PMC meta-research, 2025). Combined with limited external validation and shortcut learning, these are the recurring reasons methodologically promising studies fail Q1 review.
Example: A MAAS-coached engineering author claimed his model "outperformed" prior work from a single run. His mentor had him add repeated runs, confidence intervals, and a significance test, then soften the claim to what the data supported. The honest, well-tested version was far harder for a reviewer to reject.
How should you handle reproducibility — code, data, and model availability?
Direct answer: Plan for reproducibility from the start: share your code, document the exact data and preprocessing, and state a clear data- and model-availability position. Even where code release is not strictly mandatory, a manuscript without a reproducibility commitment draws extra reviewer scrutiny at top journals.
Evidence: At IEEE TMI, code availability, model release, and data availability are increasingly expected, and papers without a code-availability commitment may face additional scrutiny (IEEE TMI editorial guidance, 2024). The CLAIM 2024 Update is explicitly designed to promote transparency and reproducibility, asking authors to document data sources, model details, and evaluation so others can verify the work.
Example: A Vietnamese researcher worried that sharing code would expose unfinished work. Her MAAS mentor helped her prepare a clean, documented repository with a clear license and a data-availability statement, turning a perceived risk into a credibility signal that strengthened the submission.
How can Vietnamese and ESL researchers strengthen a medical-AI submission?
Direct answer: Lean on three things: a methodology checked against the right reporting guideline, clear and concise English, and developmental feedback from someone who has reviewed for Q1 journals. Catching methodological gaps and language issues before submission is what separates a desk rejection from a paper that reaches review.
Evidence: Vietnam's research strategy targets a 15–20% annual rise in WoS/Scopus/Q1 output and ties PhD progression to international publication (Vietnam national science program, 2024–2025), so demand for rigorous, well-reported medical-AI work is rising. Reporting-guideline adherence measurably improves manuscript quality, and poor language remains a recurring cause of negative first impressions at international journals.
Example: A MAAS mentor coached a Vietnamese medical-AI author through the Outline → Draft → Final model: an outline mapped to CLAIM, a draft with external validation and significance testing, and a final language and reproducibility polish. The author stayed the author throughout, with the mentor advising at each stage rather than writing the paper.
Frequently asked questions
Do I need to submit a reporting checklist with my manuscript?
Increasingly yes. Many Q1 medical and imaging journals request CLAIM or TRIPOD+AI at submission, and even when optional, completing one strengthens your paper and pre-empts reviewer questions. Check the journal's author guidelines first.
Is external validation always required for a Q1 medical-AI paper?
Not in every case, but it is expected for most clinically oriented imaging studies. If a true external dataset is impossible, be transparent about the limitation and use rigorous internal validation with no patient leakage. Hiding the gap is riskier than disclosing it.
Which is better for a first paper, IEEE TMI or a clinical imaging journal?
It depends on your contribution. A novel method with strong benchmarks fits a technical journal; a clinically framed evaluation fits a clinical imaging journal. Match the venue to your strongest contribution rather than chasing the highest-impact title.
Do I have to release my code to publish?
Not always, but top journals increasingly expect a code- and data-availability statement, and a reproducibility commitment improves your reviewer reception. Prepare a documented repository even if you release it under conditions.
How long does it take to get a medical-AI paper into a Q1 journal?
Plan for months, not weeks. Building external validation, writing to guideline standard, and peer review each take time, so a realistic timeline from a polished draft to a first decision is often several months.
Can MAAS help me publish a medical-AI study in a Q1 journal?
Yes. MAAS Publishing Advisory coaches Vietnamese researchers through feasibility assessment, methodology and reporting-guideline alignment, journal selection, and submission readiness using the Outline → Draft → Final model. Book a consultation through our contact page.
Ready to take your medical-AI study to a Q1 journal?
A medical-AI manuscript succeeds or fails on rigor and reporting long before an editor reads the results, and it is far easier to get those right with a mentor who has reviewed for top journals. MAAS Publishing Advisory pairs you with a PhD-level mentor — 23% of our experts hold doctorates — for a free 20-minute consultation, matches you to the right advisor within 48 hours, and backs every engagement with our three-tier Pass / Merit / Distinction guarantee and a 90-day post-submission warranty. We coach; you stay the author, every step.
Book a Publishing Advisory consultation with MAAS Academic Mentoring →
Related guides
- How do you choose the right Scopus journal for your paper? — matching your medical-AI contribution to the right Q1 venue
- How do you avoid predatory journals when publishing your research? — verifying a target journal is legitimate before you submit
- What is the difference between a Q1 and a Q2 journal? — how quartiles work when you weigh target journals
- How do you design a systematic review in the health sciences? — a rigorous, data-light route to a first Scopus publication
- Publishing Advisory service — full service tiers for Scopus Q1/Q2 support
- Meet the MAAS experts — the PhD-level mentors behind our publishing advisory
References
- Checklist for Artificial Intelligence in Medical Imaging (CLAIM): 2024 Update — Radiology: Artificial Intelligence
- CLAIM — RSNA AI reporting guideline page
- TRIPOD+AI statement — The BMJ (2024)
- FUTURE-AI: International consensus guideline for trustworthy and deployable AI in healthcare (2024)
- IEEE Transactions on Medical Imaging — Information for Authors
- Bias in artificial intelligence for medical imaging: fundamentals, detection, avoidance, mitigation (PMC, 2025)
- Availability and transparency of artificial intelligence models in radiology: a meta-research study (PMC)
- EQUATOR Network — CLAIM reporting guideline listing
This article is part of the MAAS Journal series for Vietnamese international postgraduate students and researchers. MAAS Publishing Advisory is an advisory partner — we coach authors through the Outline → Draft → Final delivery model with developmental feedback from PhD-level, Scopus-published mentors. We do not write, submit, or guarantee acceptance of work on an author's behalf.